Silence Therapeutics plc (SLN)

NASDAQ: SLN · Real-Time Price · USD

6.19

-0.04 (-0.64%)

At close: Mar 9, 2026, 4:00 PM EDT

6.07

-0.12 (-1.94%)

After-hours: Mar 9, 2026, 6:33 PM EDT

Silence Therapeutics Market Cap

Silence Therapeutics has a market cap or net worth of $292.38 million as of March 9, 2026. Its market cap has increased by 23.85% in one year.

Market Cap

292.38M

Enterprise Value

207.42M

1-Year Change

23.85%

Ranking

#3525

Market Cap Chart

Since September 8, 2020, Silence Therapeutics's market cap has decreased from $538.37M to $292.38M, a decrease of -45.69%. That is a compound annual growth rate of -10.52%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	294.27M	2.47%
Dec 31, 2025	287.18M	-11.59%
Dec 31, 2024	324.84M	-51.64%
Dec 29, 2023	671.70M	22.71%
Dec 30, 2022	547.37M	-23.44%
Dec 31, 2021	714.99M	17.04%
Dec 31, 2020	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Protara Therapeutics	316.16M
Nautilus Biotechnology	312.61M
XOMA Royalty	308.86M
Puma Biotechnology	307.80M
Cabaletta Bio	305.16M
C4 Therapeutics	296.64M
ALX Oncology Holdings	289.95M
Aldeyra Therapeutics	288.88M

Market Cap Rankings